LABD Dividend: Yield, Schedule, and What to Expect

Last updated August 2026

Short answer

LABD's approximate ~2.4% (variable; inverse and leveraged funds make irregular distributions) yield (as of early 2026) makes it a growth-first, low-yield fund, about $240 a year on a $10,000 position before tax. It tracks -3x daily S&P Biotech Select Industry and passes through the income its holdings generate, usually quarterly, net of the 1.07% (gross; about 0.95% net of acquired fund fees) expense ratio. If income is your goal, look to dedicated dividend funds for more; LABD is built for total return, not yield. If total return is the goal, the yield matters less than cost and what it holds. Yield is a recent snapshot, not a promise; verify the current figure with Direxion.

How does the LABD dividend work?

LABD holds what is in -3x daily S&P Biotech Select Industry, collects the income those holdings generate, and distributes it to shareholders on the schedule the fund sets, most often quarterly, net of its 1.07% (gross; about 0.95% net of acquired fund fees) fee. The yield you see is trailing distributions divided by price, so it drifts as both change: a falling price raises the quoted yield without a single extra dollar being paid out.

Direxion Daily S&P Biotech Bear 3X Shares (LABD) is a geared inverse exchange-traded fund that seeks daily investment results, before fees and expenses, equal to 300% of the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index. The fund uses swaps, futures, and short positions rather than holding a portfolio of stocks, so its disclosed holdings are derivative and cash instruments rather than individual companies. The S&P Biotechnology Select Industry Index is an equal-weighted portfolio of US biotechnology firms, a sector already known for sharp, news-driven swings around clinical trials, FDA decisions, and earnings. Applying -3x leverage to that base magnifies both gains and losses. Critically, LABD targets its -3x exposure on a single-day basis and rebalances daily. Over any holding period longer than one day, the compounding of daily returns means LABD's performance can diverge substantially from -3x the index's cumulative return, and in choppy or sideways markets this compounding works against holders, eroding value even if biotech is roughly flat. LABD carries a gross expense ratio around 1.07% (net near 0.95%), well above plain index funds, which adds a further long-term drag. It is designed for sophisticated traders seeking to profit from or hedge against short-term declines in biotech, with positions actively monitored and typically held for days, not months. Its bull counterpart is LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks +3x the same index.

What LABD's dividend pays on a real position

Approximate yield: ~2.4% (variable; inverse and leveraged funds make irregular distributions) (early 2026).
Income on $10,000: roughly $240 a year before tax, or about $2,400 on $100,000.
Versus the market: the S&P 500 yields around 1.2%, so LABD pays more.
Schedule: set by the fund, most often quarterly. Direxion publishes the exact ex-dividend and pay dates.
Fee: the 1.07% (gross; about 0.95% net of acquired fund fees) expense ratio comes out before you receive anything, so the yield above is already net of it.

How LABD distributions are taxed

A large share of LABD's distributions are usually qualified dividends, taxed at long-term capital-gains rates rather than as ordinary income, provided the holding-period tests are met by both the fund and you. Some portion can still be ordinary, and REIT or option-income components generally are. Direxion's annual 1099 shows the actual split. Inside an IRA, Roth, or 401(k) none of it applies while the money stays in the account. Full detail is in how dividends are taxed. This is not tax advice.

If income is your goal, compare LABD against dividend-focused funds. See the best dividend ETFs roundup and best ETFs for monthly income, or analyze how LABD's income fits your real portfolio in Walnut.

The bottom line on the LABD dividend

The bottom line: at an approximate ~2.4% (variable; inverse and leveraged funds make irregular distributions) yield, LABD is a growth-first, low-yield fund. If income is your goal, dedicated dividend funds pay more; LABD is the wrong tool for yield and the right one for total-return -3x daily S&P Biotech Select Industry exposure. If total return is the goal, the yield matters less than cost and what it holds. Treat the figure as a moving snapshot, not a fixed rate, and verify the current yield with Direxion.

More on LABD

What is LABD? (holdings, cost, performance, and the themes it covers)
Is LABD a buy? (what you are buying, the case for it, and what to weigh)

Investing in LABD with AI

Connect the broker you already use and ask Walnut's AI how LABD fits what you actually hold: what it overlaps with, what it leaves you exposed to, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

See how it fits your portfolio

FAQ

What is LABD's dividend yield?

Approximately ~2.4% (variable; inverse and leveraged funds make irregular distributions) as of early 2026. On a $10,000 position that is roughly $240 of distributions a year before tax. The S&P 500 yields around 1.2%, so LABD pays meaningfully more than the broad market. Yield is trailing distributions divided by price, so it moves when either changes; verify the current figure on Direxion's fund page.

How often does LABD pay a dividend?

Equity ETFs like LABD most often distribute quarterly, though the schedule is set by the fund, not by a rule, and some funds pay monthly, semi-annually, or annually. Direxion publishes LABD's distribution calendar with the exact ex-dividend and pay dates; that is the authoritative source. The mechanic that matters either way: you have to own the shares before the ex-dividend date to receive a given distribution.

Does LABD pay monthly dividends?

Probably not. LABD is an equity fund, and equity ETFs generally distribute quarterly; monthly distributions are the norm for bond, Treasury, and option-income funds instead. Check Direxion's distribution calendar for LABD's actual schedule, and see our roundup of the best ETFs for monthly income if the cadence is what you are after.

Where does LABD's dividend come from?

LABD tracks -3x daily S&P Biotech Select Industry. The fund collects the income those holdings generate and passes it through to you. The 1.07% (gross; about 0.95% net of acquired fund fees) expense ratio is taken out along the way, so the yield you see is already net of the fee: you do not pay it separately.

When is LABD's ex-dividend date?

Direxion sets and publishes it on LABD's fund page, and it moves with each distribution, so we do not quote a fixed date here. What it means is the cutoff: buy on or after the ex-dividend date and the seller keeps that distribution. Buying just before the ex-date to capture a payment is not free money, because the fund's price typically drops by roughly the distribution amount when it goes ex.

Can I reinvest LABD dividends?

Yes. Most brokers let you turn on automatic dividend reinvestment (a DRIP) so LABD distributions buy more shares, often fractional ones, without you doing anything. It compounds the position over time. It does not change the tax treatment: in a taxable account the distribution is taxable in the year it is paid, whether you reinvest it or take the cash.

Is LABD a good choice for dividend income?

Walnut is informational, not investment advice. LABD yields roughly ~2.4% (variable; inverse and leveraged funds make irregular distributions), which is moderate: real income, but below what dedicated income funds target. At that rate, $100,000 in LABD generates roughly $2,400 a year before tax. If income is the goal, dedicated dividend and income ETFs target more; LABD is built for total return. See the best dividend ETFs roundup to compare.

Are LABD dividends qualified?

Usually a large share of them are. Dividends passed through from US companies are qualified, and so taxed at long-term capital-gains rates, when the fund and you both meet the holding-period tests. Some portion can still be ordinary income, and option-income and REIT distributions generally are. Direxion's annual 1099 shows the actual split. In an IRA or Roth the distinction does not matter. This is not tax advice.

Walnut is informational, not investment advice. Dividend yields and schedules are approximate, stamped to early 2026, and change; verify current figures with Direxion or your broker.